Dedicated to better eye care for everyone
PlenOptika brings cutting-edge optical technology to eye care professionals and healthcare providers worldwide. Our flagship product, QuickSee™, is the world’s most accurate handheld autorefractor. Combining an open and binocular view, wavefront aberrometry, and continuous measurements in a field-durable hand-held format, QuickSee enables clinically accurate autorefraction anywhere.
PlenOptika technology combines excellent engineering, creative innovation, and a steadfast focus on human-centered design to meet the global challenge of low vision. Our core platform technology, the patented PlenOptika Wavefront Refraction Engine, offers eye care professionals and healthcare providers an unprecedented combination of clinical power and usability suited equally for the modern clinic, optical retail store, home visit, and global health mission. QuickSee has measured more than 2 million eyes to date in over 15 countries.
Discovering the global burden of low vision, PlenOptika’s founders determined to design a solution that could provide better eye care for everyone, regardless of their circumstances and access to health care. The company has strong research and development relationships with institutions and agencies around the world, including the Aravind Eye Hospital (India), the Regional Government of Madrid (Spain), the National Institutes of Health, and the Massachusetts Institute of Technology—where our technology was invented and the first prototypes were designed. Based in Boston, Massachusetts, we have offices in Madrid and Singapore, and we’re proud to count among our board and advisors some of the world’s leading experts in optical science, clinical eye care, and business strategy.
Peer-reviewed research publications confirm our technology’s accuracy. Our research has been published in BMJ Open Ophthalmology, Optometry and Vision Science, Investigative Ophthalmology & Visual Science, and Annual Review of Biomedical Engineering. Highlights from our research show there was no statistically significant difference in the preferences for eyeglasses derived from subjective refraction versus those from QuickSee autorefraction, and that QuickSee provides measurements that agree more closely with subjective refraction than other handheld autorefractors.
PlenOptika and QuickSee have been recognized internationally by Essilor, ASME, Indo-US Science Technology Forum Endowment Fund, the Hult Prize, Beazley Designs of the Year, and MassChallenge and many others. We have been covered by Bloomberg Businessweek, MIT News, Vision Monday, FastCompany, the Boston Globe and other news outlets.
Initial funding for the Quicksee technology was provided by the Ministry of Education of the Madrid Region, Spain, through the Madrid-MIT M+Visión Consortium, managed by the Madri+d Foundation and MIT.
With funding from
With support from
SOLIDWORKS license generously provided by the SOLIDWORKS for Entrepreneurs program. Renderings created by Chris Mowatt of TriMech Solutions using SOLIDWORKS Visualize.
Awards and recognition
MIT $100k Entrepreneurship Competition, May 2012
PlenOptika (then called ‘IoVista’) was selected as a Finalist for the competition and won the Segal Family Foundation Emerging Markets Track Prize.
Mass Challenge Entrepreneurial Accelerator, October 2012
PlenOptika was selected as a Finalist (from among more than 1,000 companies), and won the Perkins School for the Blind Assistive Technology Prize.
- MIT-MISTI India Technology Innovation Fund, December 2012
We won a travel grant to support travel for the four founders of PlenOptika to travel to India for field and market research.
Harvard Social Enterprise Conference, February 2013
PlenOptika’s pitch for QuickSee took 3rd place in the Pitch for a Change / Dell Social Innovation Challenge.
- Harvard Innovation Lab, May 2013
PlenOptika was a finalist in the Harvard President’s Challenge and won the runner-up prize of $10,000.
- SPIE Startup Challenge
PlenOptika’s pitch for the QuickSee won the 2nd place in the 2014 SPIE startup Challenge, winning $5000.
PlenOptika reached the Hult Prize regional finals in Boston, bypassing thousands of online entries for inclusion.
Indo-US Science Technology Forum Endowment Fund
PlenOptika and Aurolab have applied to the Indo-US Science Technology Forum Endowment fund in a partnership and are short-listed finalists.
Clearly Vision Prize
Special recognition for detection solutions.
Essilor See Change Prize
Special Grand Jury Prize
2017 Finalist (in progress)
TiE Scaleup Accelerator
Accepted to 2017 Fall Cohort.